Restricting Ketamine Would Have ‘Dire Consequences’ for Surgery in Low-Resource Countries, Anesthesiologists Warn

This post was originally published on this site

Proposals to restrict access to ketamine by making it a “Schedule I” drug would have a major impact on the availability of anesthesia and surgery in low- to middle-income countries (LMICs)–where ketamine is often the only general anesthetic drug available, according to a series of commentaries in Anesthesia & Analgesia.